Vialwirebiotech, curated
September 30, 2026, 3:48 AM
September 21, 2026
- 2:20 PM · Pharmaceutical Executive2:20 PM<![CDATA[Pharmaceutical Executive Daily: AbbVie Forms Ai-Powered Drug Discovery Partnership with Lambic]]> — Pharmaceutical Executive
- 12:45 PM · Nikkei Asia12:45 PMJapan aims to ensure domestic vaccine production capacity for next crisis — Nikkei Asia
- 12:00 PM · BioWorld12:00 PMBeacon readies BLA after pivotal win with ocular gene therapy — BioWorld
- 12:00 PM · BioWorld12:00 PMEMA says no to conditional approval of Maat's Xervyteg — BioWorld
- 12:00 PM · BioWorld12:00 PMIntrabio’s Aqneursa wins FDA nod as first ataxia-telangiectasia drug — BioWorld
- 11:08 AM · STAT News11:08 AMSTAT+: Lilly’s breast cancer combo wins approval — STAT News
- 10:36 AM · Pharmaceutical Technology10:36 AMBeijing unveils blueprint for biomedical dominance by 2030 — Pharmaceutical Technology
- 10:14 AM · Pharmaceutical Executive10:14 AM<![CDATA[Roundup: AbbVie & Lambic Enter Ai Drug Discovery Collaboration, Telix Merges with ITM ]]> — Pharmaceutical Executive
- 9:52 AM · Pharmaceutical Executive9:52 AM<![CDATA[CagriSema Tops Eli Lilly's Tirzepatide for Weight Loss in Late-Stage Diabetes Trial: Report ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMMaze Therapeutics discloses new SLC6A19 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMEli Lilly discovers new KRAS (G12D mutant) inhibitors — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMChengdu Zeling Biomedical Technology identifies new PARP-1 inhibitors — BioWorld
- 7:30 AM · BioPharma Dive7:30 AMHow J&J paved the way for Compass’ coming psychedelic drug launch — BioPharma Dive
- 7:00 AM · Drug Discovery World7:00 AMRoche and Dualitas Therapeutics agree $1b bispecific antibodies deal — Drug Discovery World
- 7:00 AM · STAT News
- 6:00 AM · Drug Discovery World6:00 AMDeep Science Ventures veterans launch Big Picture Bio — Drug Discovery World
- 5:33 AM · STAT News
- 5:00 AM · Drug Discovery World5:00 AMCircio raises NOK 200 million towards in vivo CAR-T programme — Drug Discovery World
- 3:38 AM · Pharmaceutical Technology3:38 AMSandoz and mAbxience agree on emicizumab biosimilar partnership — Pharmaceutical Technology
September 20, 2026
- 7:25 PM · STAT News7:25 PMSTAT+: Radiopharma companies merge after one receives surprise FDA rejection — STAT News